Evidence map›Paper›PMID 26719340›Full record

ArticleThe Journal of biological chemistry2016

The E3 Ubiquitin Ligase Adaptor Protein Skp1 Is Glycosylated by an Evolutionarily Conserved Pathway That Regulates Protist Growth and Development.

Kazi Rahman, Peng Zhao, Msano Mandalasi, Hanke van der Wel, Lance Wells, Ira J Blader, Christopher M West

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. mSphere · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. ProteinParasitology · 2019
    Review
  18. Article
  19. Article
  20. Nucleocytoplasmic O-glycosylation in protists.Current opinion in structural biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kazi RahmanFrom the Departments of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, the Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602, the Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104.
Peng Zhaothe Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602, the Complex Carbohydrate Research Center, Athens, Georgia 30602, and.
Msano MandalasiFrom the Departments of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, the Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602.
Hanke van der WelFrom the Departments of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, the Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602.
Lance Wellsthe Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602, the Complex Carbohydrate Research Center, Athens, Georgia 30602, and.
Ira J Bladerthe Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, the Department of Microbiology and Immunology, University at Buffalo, Buffalo, New York 14214.
Christopher M WestFrom the Departments of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, the Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602, westcm@uga.edu.
University of Georgia · USUniversity of Oklahoma Health Sciences Center · US

Funding

CONTROL OF TOXOPLASMA GONDII GROWTH BY THE HOST CELL TRANSCRIPTION FACTOR HIF1R01AI069986 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BLADER, IRA J · 2006 to 2021
$5.7M
Glycoregulation of Skp1 in the cytoplasm and nucleusR01GM084383 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BLADER, IRA J, WEST, CHRISTOPHER M. · 2009 to 2018
$2.9M
NIAID NIH HHS R01 AI069986NIAID NIH HHS R01-AI069986NIGMS NIH HHS R01 GM084383NIGMS NIH HHS R01-GM084383
6 · The paper itself

Abstract

Toxoplasma gondii is a protist parasite of warm-blooded animals that causes disease by proliferating intracellularly in muscle and the central nervous system. Previous studies showed that a prolyl 4-hydroxylase related to animal HIFα prolyl hydroxylases is required for optimal parasite proliferation, especially at low O2. We also observed that Pro-154 of Skp1, a subunit of the Skp1/Cullin-1/F-box protein (SCF)-class of E3-ubiquitin ligases, is a natural substrate of this enzyme. In an unrelated protist, Dictyostelium discoideum, Skp1 hydroxyproline is modified by five sugars via the action of three glycosyltransferases, Gnt1, PgtA, and AgtA, which are required for optimal O2-dependent development. We show here that TgSkp1 hydroxyproline is modified by a similar pentasaccharide, based on mass spectrometry, and that assembly of the first three sugars is dependent on Toxoplasma homologs of Gnt1 and PgtA. Reconstitution of the glycosyltransferase reactions in extracts with radioactive sugar nucleotide substrates and appropriate Skp1 glycoforms, followed by chromatographic analysis of acid hydrolysates of the reaction products, confirmed the predicted sugar identities as GlcNAc, Gal, and Fuc. Disruptions of gnt1 or pgtA resulted in decreased parasite growth. Off target effects were excluded based on restoration of the normal glycan chain and growth upon genetic complementation. By analogy to Dictyostelium Skp1, the mechanism may involve regulation of assembly of the SCF complex. Understanding the mechanism of Toxoplasma Skp1 glycosylation is expected to help develop it as a drug target for control of the pathogen, as the glycosyltransferases are absent from mammalian hosts.

Indexed as

Models, MolecularProtein Processing, Post-TranslationalAmino Acid SequenceCells, CulturedConserved SequenceEvolution, MolecularGene DeletionGlycopeptidesGlycosylationGlycosyltransferasesHumansHydroxyprolineMolecular Sequence DataOligosaccharidesProtozoan ProteinsSequence AlignmentGlycopeptidesGlycosyltransferasesHydroxyprolineOligosaccharidesProtozoan ProteinsSKP Cullin F-Box Protein LigasesS-Phase Kinase-Associated Proteinscytoplasmic glycosylationE3 ubiquitin ligaseglycobiologyglycosyltransferaseparasitologySCF-complexSkp1Toxoplasma gondii

Identifiers

PMID26719340
PMCPMC4813455
OpenAlexW2235050772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.